As of June 1, 2025, United American Healthcare Corp (UAHC) reports a ROE (Return on Equity) of 17.63%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of United American Healthcare Corp's ROE (Return on Equity)
Over recent years, United American Healthcare Corp's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2013-12-31 | 17.63% |
| 2013-06-30 | 17.63% |
| 2012-06-30 | -75.13% |
| 2011-06-30 | -164.84% |
| 2010-06-30 | -53.85% |
This slight downward trend highlights how United American Healthcare Corp manages its efficiency in generating profits from shareholders' equity over time.
Comparing United American Healthcare Corp's ROE (Return on Equity) to Peers
To better understand United American Healthcare Corp's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| United American Healthcare Corp (UAHC) | 17.63% |
| Echo Therapeutics Inc (ECTE) | 878.82% |
| Biolife Sciences Inc (BLFE) | 747.83% |
| Bionoid Pharma Inc (BINP) | 541.05% |
| ArtVentive Medical Group Inc (AVTD) | 365.48% |
| Medizone International Inc (MZEIQ) | 44.29% |
Compared to its competitors, United American Healthcare Corp's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.